U.S. Department of Justice Antitrust Update

You are subscribed to Antitrust for U.S. Department of Justice. This information has recently been updated, and is now available.

Justice Department Issues Business Review Letter to AmerisourceBergen Supporting Distribution of Critical Medicines Under Expedited Procedure for COVID-19 Pandemic Response

04/20/2020 12:00 AM EDT

The Department of Justice announced today that it will not challenge collaborative efforts of AmerisourceBergen Corporation (AmerisourceBergen) to identify global supply opportunities, ensure product quality, and facilitate product distribution of medications and other healthcare supplies to treat COVID-19 patients.

---

 |  |  |  

---

You have received this e-mail because you have asked to be notified of changes to the U.S. Department of Justice website. GovDelivery is providing this service on behalf of the Department of Justice 950 Pennsylvania Ave., NW · Washington, DC 20530 · 202-514-2000 and may not use your subscription information for any other purposes.

Manage your Subscriptions | Department of Justice Privacy Policy  | GovDelivery Privacy Policy